Azithromycin To Prevent Bronchopulmonary Dysplasia in Ureaplasma-Infected Preterm Infants: Pharmacokinetics, Safety, Microbial Response, and Clinical Outcomes with a 20-Milligram-per-Kilogram Single Intravenous Dose

Ureaplasma respiratory tract colonization is associated with bronchopulmonary dysplasia (BPD) in preterm infants. Previously, we demonstrated that a single intravenous (i.v.) dose of azithromycin (10 mg/kg of body weight) is safe but inadequate to eradicate Ureaplasma spp. in preterm infants. We per...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Viscardi, Rose M., Othman, Ahmed A., Hassan, Hazem E., Eddington, Natalie D., Abebe, Elias, Terrin, Michael L., Kaufman, David A., Waites, Ken B.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2013
Materias:
Pharmacology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3632913/
https://ncbi.nlm.nih.gov/pubmed/23439637
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02183-12
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares